Jose Lopez Cintron, MD
Obstetrics & Gynecology · Orange City, FLNPI 1770536575
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.7% of the total across 156 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 23 manufacturers reported payments, led by AbbVie at 28.6% of the total. Reporting peaked in 2019 at $824 and has fallen 65.2% since, to $287 in 2025.
Across 156 payments — averaging $18.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$844
- Mayne Pharma Commercial LLC$332
- Amarin Pharma, Inc.$263
- Millicent US Inc$263
- Shield Therapeutics Inc$255
- Pfizer$249
- plus $745 from 17 others
What the payments were for
- Food & beverage$2,88498%
- Education$682%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 32 | $844 |
| Mayne Pharma Commercial LLC | 32 | $332 |
| Amarin Pharma, Inc. | 14 | $263 |
| Millicent US Inc | 13 | $263 |
| Shield Therapeutics Inc | 9 | $255 |
| Pfizer | 19 | $249 |
| Avion Pharmaceuticals | 9 | $133 |
| Duchesnay USA Incorporated | 3 | $132 |
| Astellas Pharma US Inc | 4 | $86 |
| Amgen | 2 | $47 |
| Therapeuticsmd, Inc. | 2 | $43 |
| Hologic Sales And Service, LLC | 2 | $39 |
| Azurity Pharmaceuticals, Inc. | 2 | $35 |
| Bayer | 1 | $32 |
| Myovant Sciences Inc. | 2 | $31 |
| Currax Pharmaceuticals LLC | 2 | $29 |
| Mission Pharmacal Company | 2 | $27 |
| Lilly USA, LLC | 1 | $22 |
| Exeltis, USA Inc. | 1 | $21 |
| Acella Pharmaceuticals, LLC | 1 | $20 |
| Coopersurgical, Inc. | 1 | $18 |
| Organon | 1 | $16 |
| Vertical Pharmaceuticals, LLC | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,952 in reported general payments places this provider in the 80th percentile of 2,438 obstetrics & gynecology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ProgesteroneProgesterone, Micronized | 49 | $1,582 |
| Estradiol | 22 | $912 |
| ValacyclovirValacyclovir Hcl | 11 | $309 |
| Spironolactone | 27 | $300 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Orange City
- Steven McCarusCelebration$2.3M
- Elliot CazesTampa$725K
- Charles BloomWinter Park$652K
- Jay CohenPlantation$556K
- Omar ZwainWinter Park$531K
- Keith AquaWellington$473K
- Jeffrey KotzenPalm Beach Gardens$413K
- Glenn BankertCrestview$388K
- Erica StockwellCelebration$321K
- Scott JordanFort Lauderdale$316K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.